-
Huawei, Nokia and others share why Brazil is becoming a bigger part of their global patent strategies
Read more: Huawei, Nokia and others share why Brazil is becoming a bigger part of their global patent strategiesJudges, experts, and attorneys shared their perspectives during Licks Attorneys’ ICT Patent Litigation Seminar on Technical and Scientific Evidence 2026.
-
New Munich FRAND guidelines contemplate range from €0.49 to €1.05 per streaming service subscriber as monthly aggregate royalty burden
Read more: New Munich FRAND guidelines contemplate range from €0.49 to €1.05 per streaming service subscriber as monthly aggregate royalty burdenThe Munich I Regional Court’s 7th Civil Chamber’s FRAND guidelines discuss reasonable SEP royalty burdens for standard and premium subscriptions to streaming services.
-
German Federal Patent Court leans toward invalidating Malikie patent asserted against Xiaomi in Munich
Read more: German Federal Patent Court leans toward invalidating Malikie patent asserted against Xiaomi in MunichGermany’s Federal Patent Court has signaled it will likely invalidate a Malikie patent Xiaomi is fighting in a Munich infringement case, though the opinion is preliminary and non-binding.
-
UPC Court of Appeal upholds Abbott’s glucose sensor patent: rejects Sibio’s added matter, inventive step attacks
Read more: UPC Court of Appeal upholds Abbott’s glucose sensor patent: rejects Sibio’s added matter, inventive step attacksThe UPC Court of Appeal has dismissed Sibio’s bid to revoke Abbott’s continuous glucose monitor patent, confirming its own earlier finding from a related injunction case and issuing two headnotes that will guide how the court treats omitted features in future added matter disputes.
-
China’s top court overturns Nefecon generic PI despite U.S. Paragraph III-style no-launch pledgeÂ
Read more: China’s top court overturns Nefecon generic PI despite U.S. Paragraph III-style no-launch pledgeÂA Chinese generic of Nefecon obtained formal approval after promising not to launch until patent expiry, then used that approval to seek procurement listings. China’s top court nevertheless held that the broken Paragraph III-style pledge was a regulatory breach – not an admission of patent infringement.
-
UPC Roundup (1 week): EPO appeal leads to Munich LD stay; Munich LD flags novel damages issues; and more
Read more: UPC Roundup (1 week): EPO appeal leads to Munich LD stay; Munich LD flags novel damages issues; and moreThis is a summary of developments in and around the UPC in the calendar week of August 10, 2026.
-
Federal Circuit affirms invalidation of Nielsen’s audience-measurement patent, backs PTAB’s “reasonably pertinent” prior art finding
Read more: Federal Circuit affirms invalidation of Nielsen’s audience-measurement patent, backs PTAB’s “reasonably pertinent” prior art findingThe Federal Circuit affirmed a PTAB ruling invalidating Nielsen’s audience-measurement patent, holding that a facial-expression research paper qualified as “reasonably pertinent” prior art despite coming from a different research field.
-
EWHC hinders Accord’s plans to launch Entresto competing product in Novartis patent dispute
Read more: EWHC hinders Accord’s plans to launch Entresto competing product in Novartis patent disputeMr. Justice Meade of the High Court of Justice for England & Wales has held that all of Accord’s “attacks” on a Novartis Entresto patent have failed, and its own intended competing product would infringe the defendant’s supplementary protection certificate.


